| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 13 |
| 1 | ACETAMINOPHEN | 11 |
| 2 | DEXAMETHASONE | 10 |
| 3 | DEXAMETHASONE 1.5 MG | 10 |
| 4 | GABAPENTIN | 9 |
| 5 | LENALIDOMIDE | 9 |
| 6 | BORTEZOMIB | 7 |
| 7 | RITUXIMAB | 7 |
| 8 | VENETOCLAX | 7 |
| 9 | ACETAMINOPHEN 500MG | 6 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BENZNIDAZOLE | 1 | 0.0098 |
| 1 | ASCORBIC ACID, THIAMINE, RIBOFLAVIN, NIACINAMIDE, PYRIDOXINE, FOLIC ACID, COBALAMIN, BIOTIN, PANTOTHENIC ACID | 1 | 0.0016 |
| 2 | METHENAMINE HIPPURATE | 1 | 0.0008 |
| 3 | DOXYCYCLINE MONOHYDRATE | 1 | 0.0006 |
| 4 | DOLUTEGRAVIR SODIUM AND RILPIVIRINE HYDROCHLORIDE | 1 | 0.0006 |
| 5 | TAFAMIDIS | 5 | 0.0004 |
| 6 | ALGLUCOSIDASE ALFA | 1 | 0.0004 |
| 7 | OPICAPONE | 1 | 0.0004 |
| 8 | MARIBAVIR | 1 | 0.0004 |
| 9 | ARTIFICIAL TEARS | 1 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 25 |
| 1 | Thalidomide Analog [EPC] | 13 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 10 |
| 3 | Kinase Inhibitor [EPC] | 9 |
| 4 | Proteasome Inhibitor [EPC] | 9 |
| 5 | BCL-2 Inhibitor [EPC] | 7 |
| 6 | Benzodiazepine [EPC] | 7 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 7 |
| 8 | Dihydropyridine Calcium Channel Blocker [EPC] | 6 |
| 9 | Expectorant [EPC] | 6 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Endoglycosidase [EPC] | 1 | 0.0005 |
| 1 | CD38-directed Cytolytic Antibody [EPC] | 3 | 0.0005 |
| 2 | Cytomegalovirus pUL97 Kinase Inhibitor [EPC] | 1 | 0.0004 |
| 3 | Plasma Volume Expander [EPC] | 1 | 0.0003 |
| 4 | Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] | 1 | 0.0003 |
| 5 | Catechol-O-Methyltransferase Inhibitor [EPC] | 1 | 0.0002 |
| 6 | Recombinant Human Growth Hormone [EPC] | 3 | 0.0001 |
| 7 | Provitamin D2 Compound [EPC] | 4 | 0.0001 |
| 8 | BCL-2 Inhibitor [EPC] | 7 | 0.0001 |
| 9 | Thyroid Hormone Synthesis Inhibitor [EPC] | 1 | 0.0001 |